Let's Win Pancreatic Cancer plays a critical role in getting research to patients, to transform outcomes. 💜
USA- National
Joined November 2015
- Tweets51.6K
- Following4.4K
- Followers8.1K
- Likes28.1K
Pinned Tweet
Nuevos tratamientos están dando razones para tener esperanza frente al cáncer de páncreas. Acompáñenos en el seminario web Let’s Learn con el Dr. Arturo Loaiza-Bonilla (@DrArturoAI) y Catalina Fandino.
Jueves 29 de oct., 2 p. m. ET 💜
Regístrese: us02web.zoom.us/webinar/regi…
ALT A webinar announcement for a pancreas cancer seminar titled "Cáncer de páncreas: Los tratamientos más recientes" on October 29 at 2:00 p.m. ET. The speakers include Arturo Loaiza-Bonilla, Catalina Fandiño, and Juan Pellerano-Rendón. Logos at the bottom include LetsWin, Nuestras Voces Adelante, and Novocure.
About 10% of pancreatic cancer patients have neuroendocrine tumors (PNETs). How are they different? Dr. @DianeReidyLagun of @DukeHealth joins @AlisynCamerota on #PancChat to explain diagnosis, treatment, and why expertise matters. 🎧 youtu.be/zSltAxo1w0M
PancChat is a collaboration between Let's Win and @PanCAN, available on all major podcast platforms.
Lead investigator Dr. Jeffrey Crawford reports on the positive results from a clinical trial of a new immunotherapy drug to treat cachexia. bit.ly/41xHp3K
Next up in our "Why I'm Running" series: Michael.
He's running the TCS New York City Marathon in honor of Dr. Marta Rendón, who passed away from pancreatic cancer and was the mother of his close friend Juan Pellerano-Rendón. .
Support Michael's run: bit.ly/4yxtBnB
Let's Win Pancreatic Cancer 💜 retweeted
Beyond excited to recruit @VivekSubbiah to @nyulangone @Perlmutter_CC as the new director of our Early Phase Drug Development Program and the Rare Cancer Program.
Congratulate Vivek when you see him at #ESMO26. Welcome to NYC!
@JohnPLeonardMD
nyulangone.org/news/perlmutt…
When Cancer Calls an Audible: After a pancreatic cancer diagnosis upended his life and career, one survivor reflects on treatment, resilience, and finding hope more than a decade later. via @cure_today curetoday.com/view/when-canc…
Nuevos tratamientos están dando razones para tener esperanza frente al cáncer de páncreas. Acompáñenos en el seminario web Let’s Learn con el Dr. Arturo Loaiza-Bonilla (@DrArturoAI) y Catalina Fandino.
Jueves 29 de oct., 2 pm ET 💜
us02web.zoom.us/webinar/regi…
ALT A webinar announcement for a pancreas cancer seminar titled "Cáncer de páncreas: Los tratamientos más recientes" on October 29 at 2:00 p.m. ET. The speakers include Arturo Loaiza-Bonilla, Catalina Fandiño, and Juan Pellerano-Rendón. Logos at the bottom include LetsWin, Nuestras Voces Adelante, and Novocure.
When a loved one is being treated for pancreatic cancer, caregivers become at-home nurses. Marci Andrejko provides some best practices. bit.ly/4mpiSGX
Dr. Suresh Chari outlines interim study results that confirm the link between new-onset diabetes and pancreatic cancer. bit.ly/47b2Zhf
Let's Win Pancreatic Cancer 💜 retweeted
Nuevos tratamientos están dando razones para tener esperanza frente al cáncer de páncreas. Acompáñenos en el seminario web Let’s Learn con el Dr. Arturo Loaiza-Bonilla (@DrArturoAI) y Catalina Fandino.
Jueves 29 de oct., 2 p. m. ET 💜
Regístrese: us02web.zoom.us/webinar/regi…
ALT A webinar announcement for a pancreas cancer seminar titled "Cáncer de páncreas: Los tratamientos más recientes" on October 29 at 2:00 p.m. ET. The speakers include Arturo Loaiza-Bonilla, Catalina Fandiño, and Juan Pellerano-Rendón. Logos at the bottom include LetsWin, Nuestras Voces Adelante, and Novocure.
Let's Win Pancreatic Cancer 💜 retweeted
Honored to have #Atebimetinib on the cover of Cancer Research, and grateful to the entire @Immuneering $IMRX team for years of persistent, data-driven hard work on behalf of cancer patients ... full speed ahead!
On the cover of the October 15 issue—Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass doi.org/10.1158/0008-5472.CA… @jmfunt @benzeskind @Immuneering #MEKInhibitor #OpenAccess
Let's Win Pancreatic Cancer 💜 retweeted
Excellent review in @CCR_AACR by @Dr_R_Kurzrock on an important non-RAS target in oncology, Claudin 18.2. Cancer adapts fast, so alternating between non-RAS and RAS targets in sequence may become an important strategy for maximizing survival. Yet non-RAS targets tend to fly under the radar these days. In pancreatic cancer in particular, Claudin 18.2 is important (for ~30% of patients); so is MEK (for almost all patients, and our focus at @Immuneering $IMRX with #atebimetinib), PRMT5 (for patients with MTAP deletions), CD73, GSK-3beta, and others. Have a non-RAS target in pancreatic cancer you think deserves more attention? Please add to the comments …
@PanCAN @letswinpc #PancreaticCancer #PDAC
My posts contain forward looking statements about Immuneering: please refer to our SEC filings for more information.
Let's Win Pancreatic Cancer 💜 retweeted
🇪🇺Europe is stepping up in the treatment of
#PancreaticCancer with the first Multidisciplinary #Guidelines and the #PALACROS project 🔥
🤝Involving over 30 societies and patient organizations, 15 countries and 60+ centers across Europe
🙌Thanks to @my_ueg (14,000+ attendees!) for highlighting these developments!
🔗#PALACROS including the #PREOPANC4 RCT #PULSE and #PIVOTAL trials: pancreaticcancereurope.eu/pr…
🔗#Guidelines protocol: pancreaticcancereurope.eu/pr…
Let's Win Pancreatic Cancer 💜 retweeted
ASCO Leads: Latin America applications open! Apply by 10/26 to join us in Costa Rica Feb. 11-12, 2027, for leadership training & premier networking. Designed for mid-career ASCO Members currently practicing oncology in the Latin America region. Learn more: bit.ly/4ynK1ig
Let's Win Pancreatic Cancer 💜 retweeted
🚨⭐️⭐️⭐️📍📌 Mark your calendars 📅 @myESMO MADRID
📍Saturday, Oct 24 · 14:45–15:45 · Santander Auditorium, Hall 10
👉Delighted to be delivering a lecture: “Drugging the Undruggables: The Next Wave of Targeted Therapies #PrecisionOncology.” 🧬🎯beyond KRAS, P53, MYC & much much more @Annals_Oncology #ESMOAmbassadors
👉Session: “YO Lecture: What to expect from precision medicine in the next decade” #ESMO26 #PrecisionOncology #TargetedTherapy
👉I’ll be presenting the latest+ greatest in the field, and looking for what comes next.
👉👉👉PLEASE ATTEND + Come with questions @OncoAlert @Aiims1742 @BalazsHalmosMD @oncologiaroma @PTarantinoMD @curijoey @FAndreMD @CharlesSwanton
Session LINK: cslide.ctimeetingtech.com/es…
At the 2026 AACR Pancreatic Cancer conference, researchers reported on daraxonrasib and other KRAS targeting drugs. bit.ly/4BezicZ
Let's Win Pancreatic Cancer 💜 retweeted
Elvin Howard Jr of the Elvin Howard Sr. Pancreatic Cancer Advocacy Foundation joins @talk1073 @JaguarJournal_ host @_WHEreIsPERRY to promote pancreatic cancer awareness as well as the upcoming 5K run/1mile walk
🔽Learn More By Clicking The Link Below🔽
elvinhowardsrpcaf.org
How can you tell if a scientific study is good? Learn what to look for in reliable studies and whether a trial may be right for you. bit.ly/4jRi9fr
A tumor board brings together experts in different treatment fields to discuss your case and help direct your pancreatic cancer treatment. bit.ly/49f1KOd
